Issue Date: June 2, 2008
Lonza Buys Cell Technology Firm
Lonza has acquired Amaxa, a leader in gene-transfer technology, for an undisclosed sum. The Cologne, Germany-based firm manufactures systems that enable transfer of nucleic acids such as DNA and RNA into cells. Lonza says Amaxa will triple the size of its cell-related R&D operations based in Walkersville, Md. Amaxa's transfer technology is seen as complementary to Lonza's current activity, which is centered on primary cell production.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society